
4-hydroxy-3-methylbenzoic acid
CAS No. 499-76-3
4-hydroxy-3-methylbenzoic acid( 43-Cresotic acid )
Catalog No. M20003 CAS No. 499-76-3
4-Hydroxy-3-methylbenzoic acid is a normal organic acid identified in urine specimens from a healthy population.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | 37 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Name4-hydroxy-3-methylbenzoic acid
-
NoteResearch use only, not for human use.
-
Brief Description4-Hydroxy-3-methylbenzoic acid is a normal organic acid identified in urine specimens from a healthy population.
-
Description4-Hydroxy-3-methylbenzoic acid is a normal organic acid identified in urine specimens from a healthy population.
-
In Vitro4-Hydroxy-3-methylbenzoic acid was isolated as the product of oxidation of 2,4-xylenol by cells inhibited with alpha alpha'-bipyridyl.
-
In Vivo——
-
Synonyms43-Cresotic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number499-76-3
-
Formula Weight152.15
-
Molecular FormulaC8H8O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:200 mM
-
SMILESCc1cc(ccc1O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guneral F et al. Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.
molnova catalog



related products
-
Gizzerosine HCl
Gizzerosine 2HCl a substance produced during the heat treatment of fishmeal, induces histopathological lesions in broiler chicks and increases intracellular cyclic adenosine-3',5'-monophosphate levels in isolated chickens of origin.
-
Cetraxate HCl
Cetraxate HCl is an oral gastrointestinal medication. It has a cytoprotective effect.
-
V2 receptor (V2R) a...
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively.